APA (7th ed.) Citation

C, S., I, T., A, K., V, P., & LE, L. (2021). Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: Findings from 11 years of reporting to a pregnancy registry. Human vaccines & immunotherapeutics, 17(12), 5325. https://doi.org/10.1080/21645515.2021.1915038

Chicago Style (17th ed.) Citation

C, Switzer, Tikhonov I, Khromava A, Pool V, and Lévesque LE. "Safety and Use of Tetanus-diphtheria-acellular Pertussis-5 (Tdap5) Vaccine During Pregnancy: Findings from 11 Years of Reporting to a Pregnancy Registry." Human Vaccines & Immunotherapeutics 17, no. 12 (2021): 5325. https://doi.org/10.1080/21645515.2021.1915038.

MLA (9th ed.) Citation

C, Switzer, et al. "Safety and Use of Tetanus-diphtheria-acellular Pertussis-5 (Tdap5) Vaccine During Pregnancy: Findings from 11 Years of Reporting to a Pregnancy Registry." Human Vaccines & Immunotherapeutics, vol. 17, no. 12, 2021, p. 5325, https://doi.org/10.1080/21645515.2021.1915038.